Company Directory / biotech
PrivateFor profitbiotechMont-Saint-Guibert, Belgium
Novadip Biosciences
Novadip is transforming the lives of patients using its unique “3M3” tissue regeneration technology platform.
- Founded
- 2013 13 years ago
- Staff
- 11-50 band, as listed
- Followers
- - on LinkedIn
- Funding
- $87M as listed, currency not stated
Set against six million companies
Size
11-50 people: larger than 33% of companies with a size listed
Age
13 years old.
Reach
Website ranked #11,655,163 in the world for traffic, about 154 visits a month.
What it does
BiotechnologyHealth CareMedicalTherapeutics
Funding, as listed
$87M currency not stated
- Rounds4
- LatestSeries b, Nov 2022
- Investors12, 4 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Novadip Biosciences, field by field. Contact details are held but never shown.
The company
- Name
- Novadip Biosciences
- Type
- For profit
- Status
- Private
- Founded
- 2013
- Founders
- Denis Dufrane, Jean- François Pollet
- Industry
- biotech
- Categories
- Biotechnology, Health Care, Medical, Therapeutics
Where
- City
- Mont-Saint-Guibert
- Country
- Belgium
- Markets
- European Union (EU), Europe, Middle East, and Africa (EMEA)
Size and reach
- Staff band
- 11-50
- Web traffic rank
- #11,655,163
- Monthly web visits
- 154
Funding, as listed
- Total
- 87,000,000 (currency not stated)
- Rounds
- 4
- Latest round
- Series b
- Latest round date
- Nov 2022
- Investors
- 12
- Lead investors
- 4
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Novadip Biosciences may be growing as it has announced significant clinical milestones for both of its clinical-stage programs. Achieving clinical milestones is indicative of progress in the biotechnology and therapeutics industry, which can lead to increased investor confidence and potential future revenue streams. This development suggests that the company is advancing its '3M3' tissue regeneration technology platform, which is central to its operations and future growth prospects.
Summaries written by the source dataset, not by us, and not checked.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 36,920 companies in Belgium and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.